메뉴 건너뛰기




Volumn 71, Issue 6, 2006, Pages 882-890

The pattern of deoxycytidine- and deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemia

Author keywords

Chronic lymphocytic leukemia; Deoxycytidine kinase; Deoxyguanosine kinase; Purine analogues

Indexed keywords

CHLORAMBUCIL; CLADRIBINE; DEOXYCYTIDINE KINASE; DEOXYGUANOSINE KINASE; FLUDARABINE; MESSENGER RNA; SMALL INTERFERING RNA;

EID: 32144448129     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2005.12.007     Document Type: Article
Times cited : (22)

References (48)
  • 2
    • 0038509118 scopus 로고    scopus 로고
    • Mechanism of action of purine analogues in chronic lymphocytic leukaemia
    • A.R. Pettitt Mechanism of action of purine analogues in chronic lymphocytic leukaemia Br J Haematol 121 5 2003 692 702
    • (2003) Br J Haematol , vol.121 , Issue.5 , pp. 692-702
    • Pettitt, A.R.1
  • 3
    • 0036125593 scopus 로고    scopus 로고
    • The role of nucleoside analogues in the treatment of chronic lymphocytic leukemia-lessons learned from prospective randomized trials
    • T. Robak The role of nucleoside analogues in the treatment of chronic lymphocytic leukemia-lessons learned from prospective randomized trials Leuk Lymphoma 43 3 2002 537 548
    • (2002) Leuk Lymphoma , vol.43 , Issue.3 , pp. 537-548
    • Robak, T.1
  • 4
    • 0036179221 scopus 로고    scopus 로고
    • Oral cladribine for B-cell chronic lymphocytic leukaemia: Report of a phase II trial with a 3-d, 3-weekly schedule in untreated and pretreated patients, and a long-term follow-up of 126 previously untreated patients
    • K. Karlsson, M. Stromberg, J. Liliemark, A. Delannoy, S.A. Johnson, and A. Porwit Oral cladribine for B-cell chronic lymphocytic leukaemia: report of a phase II trial with a 3-d, 3-weekly schedule in untreated and pretreated patients, and a long-term follow-up of 126 previously untreated patients Br J Haematol 116 3 2002 538 548
    • (2002) Br J Haematol , vol.116 , Issue.3 , pp. 538-548
    • Karlsson, K.1    Stromberg, M.2    Liliemark, J.3    Delannoy, A.4    Johnson, S.A.5    Porwit, A.6
  • 5
    • 0025890427 scopus 로고
    • Metabolism and action of purine nucleoside analogs
    • W. Plunkett, and P.P. Saunders Metabolism and action of purine nucleoside analogs Pharmacol Ther 49 3 1991 239 268
    • (1991) Pharmacol Ther , vol.49 , Issue.3 , pp. 239-268
    • Plunkett, W.1    Saunders, P.P.2
  • 6
    • 0242560897 scopus 로고    scopus 로고
    • Substrate specificity of human recombinant mitochondrial deoxyguanosine kinase with cytostatic and antiviral purine and pyrimidine analogs
    • A.H. Sjoberg, L. Wang, and S. Eriksson Substrate specificity of human recombinant mitochondrial deoxyguanosine kinase with cytostatic and antiviral purine and pyrimidine analogs Mol Pharmacol 53 2 1998 270 273
    • (1998) Mol Pharmacol , vol.53 , Issue.2 , pp. 270-273
    • Sjoberg, A.H.1    Wang, L.2    Eriksson, S.3
  • 7
    • 0037441388 scopus 로고    scopus 로고
    • Selective activation of deoxycytidine kinase by thymidine-5′- thiosulphate and release by deoxycytidine in human lymphocytes
    • G. Keszler, K. Szikla, Z. Kazimierczuk, T. Spasokoukotskaja, M. Sasvari-Szekely, and M. Staub Selective activation of deoxycytidine kinase by thymidine-5′-thiosulphate and release by deoxycytidine in human lymphocytes Biochem Pharmacol 65 4 2003 563 571
    • (2003) Biochem Pharmacol , vol.65 , Issue.4 , pp. 563-571
    • Keszler, G.1    Szikla, K.2    Kazimierczuk, Z.3    Spasokoukotskaja, T.4    Sasvari-Szekely, M.5    Staub, M.6
  • 8
    • 1042275536 scopus 로고    scopus 로고
    • Activation of deoxycytidine kinase in lymphocytes is calcium dependent and involves a conformational change detectable by native immunostaining
    • G. Keszler, T. Spasokoukotskaja, Z. Csapo, I. Talianidis, S. Eriksson, and M. Staub Activation of deoxycytidine kinase in lymphocytes is calcium dependent and involves a conformational change detectable by native immunostaining Biochem Pharmacol 67 5 2004 947 955
    • (2004) Biochem Pharmacol , vol.67 , Issue.5 , pp. 947-955
    • Keszler, G.1    Spasokoukotskaja, T.2    Csapo, Z.3    Talianidis, I.4    Eriksson, S.5    Staub, M.6
  • 9
    • 0344973660 scopus 로고    scopus 로고
    • Activation of deoxycytidine kinase during inhibition of DNA synthesis by 2-chloro-2′-deoxyadenosine (cladribine) in human lymphocytes
    • M. Sasvari-Szekely, T. Spasokoukotskaja, M. Szoke, Z. Csapo, A. Turi, and I. Szanto Activation of deoxycytidine kinase during inhibition of DNA synthesis by 2-chloro-2′-deoxyadenosine (cladribine) in human lymphocytes Biochem Pharmacol 56 9 1998 1175 1179
    • (1998) Biochem Pharmacol , vol.56 , Issue.9 , pp. 1175-1179
    • Sasvari-Szekely, M.1    Spasokoukotskaja, T.2    Szoke, M.3    Csapo, Z.4    Turi, A.5    Szanto, I.6
  • 11
    • 0032531671 scopus 로고    scopus 로고
    • Phosphorylation of anticancer nucleoside analogs by human mitochondrial deoxyguanosine kinase
    • C. Zhu, M. Johansson, J. Permert, and A. Karlsson Phosphorylation of anticancer nucleoside analogs by human mitochondrial deoxyguanosine kinase Biochem Pharmacol 56 8 1998 1035 1040
    • (1998) Biochem Pharmacol , vol.56 , Issue.8 , pp. 1035-1040
    • Zhu, C.1    Johansson, M.2    Permert, J.3    Karlsson, A.4
  • 12
    • 0036076401 scopus 로고    scopus 로고
    • Low level of mitochondrial deoxyguanosine kinase is the dominant factor in acquired resistance to 9-beta-d-arabinofuranosylguanine cytotoxicity
    • K. Lotfi, E. Mansson, C. Peterson, S. Eriksson, and F. Albertioni Low level of mitochondrial deoxyguanosine kinase is the dominant factor in acquired resistance to 9-beta-d-arabinofuranosylguanine cytotoxicity Biochem Biophys Res Commun 293 5 2002 1489 1496
    • (2002) Biochem Biophys Res Commun , vol.293 , Issue.5 , pp. 1489-1496
    • Lotfi, K.1    Mansson, E.2    Peterson, C.3    Eriksson, S.4    Albertioni, F.5
  • 13
    • 0034767094 scopus 로고    scopus 로고
    • Semiquantitative reverse transcription-polymerase chain reaction with the Agilent 2100 Bioanalyzer
    • E. Gottwald, O. Muller, and A. Polten Semiquantitative reverse transcription-polymerase chain reaction with the Agilent 2100 Bioanalyzer Electrophoresis 22 18 2001 4016 4022
    • (2001) Electrophoresis , vol.22 , Issue.18 , pp. 4016-4022
    • Gottwald, E.1    Muller, O.2    Polten, A.3
  • 14
    • 0036122781 scopus 로고    scopus 로고
    • Real-time quantitative PCR assays for deoxycytidine kinase, deoxyguanosine kinase and 5′-nucleotidase mRNA measurement in cell lines and in patients with leukemia
    • E. Mansson, E. Liliemark, S. Soderhall, G. Gustafsson, S. Eriksson, and F. Albertioni Real-time quantitative PCR assays for deoxycytidine kinase, deoxyguanosine kinase and 5′-nucleotidase mRNA measurement in cell lines and in patients with leukemia Leukemia 16 3 2002 386 392
    • (2002) Leukemia , vol.16 , Issue.3 , pp. 386-392
    • Mansson, E.1    Liliemark, E.2    Soderhall, S.3    Gustafsson, G.4    Eriksson, S.5    Albertioni, F.6
  • 15
    • 0034663307 scopus 로고    scopus 로고
    • High incidence of alternatively spliced forms of deoxycytidine kinase in patients with resistant acute myeloid leukemia
    • M.J. Veuger, M.W. Honders, J.E. Landegent, R. Willemze, and R.M. Barge High incidence of alternatively spliced forms of deoxycytidine kinase in patients with resistant acute myeloid leukemia Blood 96 4 2000 1517 1524
    • (2000) Blood , vol.96 , Issue.4 , pp. 1517-1524
    • Veuger, M.J.1    Honders, M.W.2    Landegent, J.E.3    Willemze, R.4    Barge, R.M.5
  • 16
    • 0032724360 scopus 로고    scopus 로고
    • Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12;21) TEL-AML1 fusion transcript
    • N. Pallisgaard, N. Clausen, H. Schroder, and P. Hokland Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12;21) TEL-AML1 fusion transcript Genes Chromosomes Cancer 26 4 1999 355 365
    • (1999) Genes Chromosomes Cancer , vol.26 , Issue.4 , pp. 355-365
    • Pallisgaard, N.1    Clausen, N.2    Schroder, H.3    Hokland, P.4
  • 17
    • 0037325637 scopus 로고    scopus 로고
    • A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: Results from CALGB Study 9211
    • J.C. Byrd, B. Peterson, L. Piro, A. Saven, J.W. Vardiman, and R.A. Larson A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211 Leukemia 17 2 2003 323 327
    • (2003) Leukemia , vol.17 , Issue.2 , pp. 323-327
    • Byrd, J.C.1    Peterson, B.2    Piro, L.3    Saven, A.4    Vardiman, J.W.5    Larson, R.A.6
  • 18
    • 0028087112 scopus 로고
    • High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemias
    • D.C. Betticher, M.F. Fey, A. von Rohr, A. Tobler, H. Jenzer, and A. Gratwohl High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemias Ann Oncol 5 1 1994 57 64
    • (1994) Ann Oncol , vol.5 , Issue.1 , pp. 57-64
    • Betticher, D.C.1    Fey, M.F.2    Von Rohr, A.3    Tobler, A.4    Jenzer, H.5    Gratwohl, A.6
  • 19
    • 0026675806 scopus 로고
    • Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine
    • G. Juliusson, R.A. Elmhorn, and J. Liliemark Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine N Engl J Med 327 15 1992 1056 1061 [see comments]
    • (1992) N Engl J Med , vol.327 , Issue.15 , pp. 1056-1061
    • Juliusson, G.1    Elmhorn, R.A.2    Liliemark, J.3
  • 20
    • 0030018146 scopus 로고    scopus 로고
    • Long-term survival following cladribine (2-chlorodeoxyadenosine) therapy in previously treated patients with chronic lymphocytic leukemia
    • G. Juliusson, and J. Liliemark Long-term survival following cladribine (2-chlorodeoxyadenosine) therapy in previously treated patients with chronic lymphocytic leukemia Ann Oncol 7 4 1996 373 379
    • (1996) Ann Oncol , vol.7 , Issue.4 , pp. 373-379
    • Juliusson, G.1    Liliemark, J.2
  • 21
    • 0033406797 scopus 로고    scopus 로고
    • Molecular and biochemical mechanisms of fludarabine and cladribine resistance in a human promyelocytic cell line
    • E. Mansson, T. Spasokoukotskaja, J. Sallstrom, S. Eriksson, and F. Albertioni Molecular and biochemical mechanisms of fludarabine and cladribine resistance in a human promyelocytic cell line Cancer Res 59 23 1999 5956 5963
    • (1999) Cancer Res , vol.59 , Issue.23 , pp. 5956-5963
    • Mansson, E.1    Spasokoukotskaja, T.2    Sallstrom, J.3    Eriksson, S.4    Albertioni, F.5
  • 22
    • 0037437762 scopus 로고    scopus 로고
    • Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance
    • E. Mansson, E. Flordal, J. Liliemark, T. Spasokoukotskaja, H. Elford, and S. Lagercrantz Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance Biochem Pharmacol 65 2 2003 237 247
    • (2003) Biochem Pharmacol , vol.65 , Issue.2 , pp. 237-247
    • Mansson, E.1    Flordal, E.2    Liliemark, J.3    Spasokoukotskaja, T.4    Elford, H.5    Lagercrantz, S.6
  • 23
    • 0035004335 scopus 로고    scopus 로고
    • Pharmacological basis for cladribine resistance in a human acute T lymphoblastic leukaemia cell line selected for resistance to etoposide
    • K. Lotfi, E. Mansson, J. Chandra, Y. Wang, D. Xu, and E. Knaust Pharmacological basis for cladribine resistance in a human acute T lymphoblastic leukaemia cell line selected for resistance to etoposide Br J Haematol 113 2 2001 339 346
    • (2001) Br J Haematol , vol.113 , Issue.2 , pp. 339-346
    • Lotfi, K.1    Mansson, E.2    Chandra, J.3    Wang, Y.4    Xu, D.5    Knaust, E.6
  • 24
    • 0028986279 scopus 로고
    • 2′-Deoxycytidine kinase deficiency is a major determinant of 2-chloro-2′-deoxyadenosine resistance in lymphoid cell lines
    • R.M. Orr, D.C. Talbot, W.G. Aherne, T.C. Fisher, P. Serafinowski, and K.R. Harrap 2′-Deoxycytidine kinase deficiency is a major determinant of 2-chloro-2′-deoxyadenosine resistance in lymphoid cell lines Clin Cancer Res 1 4 1995 391 398
    • (1995) Clin Cancer Res , vol.1 , Issue.4 , pp. 391-398
    • Orr, R.M.1    Talbot, D.C.2    Aherne, W.G.3    Fisher, T.C.4    Serafinowski, P.5    Harrap, K.R.6
  • 25
    • 0013040873 scopus 로고    scopus 로고
    • Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562
    • C. Dumontet, K. Fabianowska-Majewska, D. Mantincic, E. Callet Bauchu, I. Tigaud, and V. Gandhi Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562 Br J Haematol 106 1 1999 78 85
    • (1999) Br J Haematol , vol.106 , Issue.1 , pp. 78-85
    • Dumontet, C.1    Fabianowska-Majewska, K.2    Mantincic, D.3    Callet Bauchu, E.4    Tigaud, I.5    Gandhi, V.6
  • 26
    • 0031817627 scopus 로고    scopus 로고
    • Mechanisms responsible for resistance of sublines derived from leukemia cell lines to an antitumor agent 9-beta-d-arabinofuranosyl-2-fluoroadenine
    • L. Bai, M. Yamaguchi, M. Tatsumi, K. Kon, and M. Brautigam Mechanisms responsible for resistance of sublines derived from leukemia cell lines to an antitumor agent 9-beta-d-arabinofuranosyl-2-fluoroadenine J Cancer Res Clin Oncol 124 7 1998 367 373
    • (1998) J Cancer Res Clin Oncol , vol.124 , Issue.7 , pp. 367-373
    • Bai, L.1    Yamaguchi, M.2    Tatsumi, M.3    Kon, K.4    Brautigam, M.5
  • 27
    • 0029947983 scopus 로고    scopus 로고
    • Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity
    • D.M. Hapke, A.P. Stegmann, and B.S. Mitchell Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity Cancer Res 56 10 1996 2343 2347
    • (1996) Cancer Res , vol.56 , Issue.10 , pp. 2343-2347
    • Hapke, D.M.1    Stegmann, A.P.2    Mitchell, B.S.3
  • 28
    • 0016248313 scopus 로고
    • Mechanisms of resistance of human acute leukaemia cells to cytosine arabinoside
    • M.H. Tattersall, K. Ganeshaguru, and A.V. Hoffbrand Mechanisms of resistance of human acute leukaemia cells to cytosine arabinoside Br J Haematol 27 1 1974 39 46
    • (1974) Br J Haematol , vol.27 , Issue.1 , pp. 39-46
    • Tattersall, M.H.1    Ganeshaguru, K.2    Hoffbrand, A.V.3
  • 29
    • 0027525929 scopus 로고
    • Relationship of deoxycytidine kinase and cytoplasmic 5′- nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosine
    • H. Kawasaki, C.J. Carrera, L.D. Piro, A. Saven, T.J. Kipps, and D.A. Carson Relationship of deoxycytidine kinase and cytoplasmic 5′- nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosine Blood 81 3 1993 597 601
    • (1993) Blood , vol.81 , Issue.3 , pp. 597-601
    • Kawasaki, H.1    Carrera, C.J.2    Piro, L.D.3    Saven, A.4    Kipps, T.J.5    Carson, D.A.6
  • 30
    • 0028093655 scopus 로고
    • Phosphorylation of 2-chlorodeoxyadenosine (CdA) in extracts of peripheral blood mononuclear cells of leukaemic patients
    • E.S. Arner, T. Spasokoukotskaja, G. Juliusson, J. Liliemark, and S. Eriksson Phosphorylation of 2-chlorodeoxyadenosine (CdA) in extracts of peripheral blood mononuclear cells of leukaemic patients Br J Haematol 87 4 1994 715 718
    • (1994) Br J Haematol , vol.87 , Issue.4 , pp. 715-718
    • Arner, E.S.1    Spasokoukotskaja, T.2    Juliusson, G.3    Liliemark, J.4    Eriksson, S.5
  • 31
    • 0030858503 scopus 로고    scopus 로고
    • Deoxycytidine kinase mRNA expression in childhood acute lymphoblastic leukemia
    • G. Stammler, F. Zintl, A. Sauerbrey, and M. Volm Deoxycytidine kinase mRNA expression in childhood acute lymphoblastic leukemia Anticancer Drugs 8 5 1997 517 521
    • (1997) Anticancer Drugs , vol.8 , Issue.5 , pp. 517-521
    • Stammler, G.1    Zintl, F.2    Sauerbrey, A.3    Volm, M.4
  • 32
    • 0032409839 scopus 로고    scopus 로고
    • Expression of deoxycytidine kinase (dCK) gene in leukemic cells in childhood: Decreased expression of dCK gene in relapsed leukemia
    • T. Kakihara, T. Fukuda, A. Tanaka, I. Emura, K. Kishi, and K. Asami Expression of deoxycytidine kinase (dCK) gene in leukemic cells in childhood: decreased expression of dCK gene in relapsed leukemia Leuk Lymphoma 31 3-4 1998 405 409
    • (1998) Leuk Lymphoma , vol.31 , Issue.3-4 , pp. 405-409
    • Kakihara, T.1    Fukuda, T.2    Tanaka, A.3    Emura, I.4    Kishi, K.5    Asami, K.6
  • 33
    • 0038007346 scopus 로고    scopus 로고
    • Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine
    • C.M. Galmarini, X. Thomas, K. Graham, A. El Jafaari, E. Cros, and L. Jordheim Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine Br J Haematol 122 1 2003 53 60
    • (2003) Br J Haematol , vol.122 , Issue.1 , pp. 53-60
    • Galmarini, C.M.1    Thomas, X.2    Graham, K.3    El Jafaari, A.4    Cros, E.5    Jordheim, L.6
  • 34
    • 0023187987 scopus 로고
    • Phase II trial of 9-beta-d-arabinofuranosyl-2-fluoroadenine 5′-monophosphate in non-Hodgkin's lymphoma: Prospective comparison of response with deoxycytidine kinase activity
    • J.M. Leiby, K.M. Snider, E.H. Kraut, E.N. Metz, L. Malspeis, and M.R. Grever Phase II trial of 9-beta-d-arabinofuranosyl-2-fluoroadenine 5′-monophosphate in non-Hodgkin's lymphoma: prospective comparison of response with deoxycytidine kinase activity Cancer Res 47 10 1987 2719 2722
    • (1987) Cancer Res , vol.47 , Issue.10 , pp. 2719-2722
    • Leiby, J.M.1    Snider, K.M.2    Kraut, E.H.3    Metz, E.N.4    Malspeis, L.5    Grever, M.R.6
  • 35
    • 0031808792 scopus 로고    scopus 로고
    • Relationship between cladribine (CdA) plasma, intracellular CdA-5′-triphosphate (CdATP) concentration, deoxycytidine kinase (dCK), and chemotherapeutic activity in chronic lymphocytic leukemia (CLL)
    • F. Albertioni, S. Lindemalm, S. Eriksson, G. Juliusson, and J. Liliemark Relationship between cladribine (CdA) plasma, intracellular CdA-5′- triphosphate (CdATP) concentration, deoxycytidine kinase (dCK), and chemotherapeutic activity in chronic lymphocytic leukemia (CLL) Adv Exp Med Biol 431 1998 693 697
    • (1998) Adv Exp Med Biol , vol.431 , pp. 693-697
    • Albertioni, F.1    Lindemalm, S.2    Eriksson, S.3    Juliusson, G.4    Liliemark, J.5
  • 36
    • 0036757209 scopus 로고    scopus 로고
    • Deoxycytidine kinase expression and activity in patients with resistant versus sensitive acute myeloid leukemia
    • M.J. Veuger, M.W. Honders, R. Willemze, and R.M. Barge Deoxycytidine kinase expression and activity in patients with resistant versus sensitive acute myeloid leukemia Eur J Haematol 69 3 2002 171 178
    • (2002) Eur J Haematol , vol.69 , Issue.3 , pp. 171-178
    • Veuger, M.J.1    Honders, M.W.2    Willemze, R.3    Barge, R.M.4
  • 37
    • 2542444476 scopus 로고    scopus 로고
    • 5-(3)-Nucleotidase mRNA levels in blast cells are a prognostic factor in acute myeloid leukemia patients treated with cytarabine
    • C.M. Galmarini, E. Cros, K. Graham, X. Thomas, J.R. Mackey, and C. Dumontet 5-(3)-Nucleotidase mRNA levels in blast cells are a prognostic factor in acute myeloid leukemia patients treated with cytarabine Haematologica 89 5 2004 617 619
    • (2004) Haematologica , vol.89 , Issue.5 , pp. 617-619
    • Galmarini, C.M.1    Cros, E.2    Graham, K.3    Thomas, X.4    MacKey, J.R.5    Dumontet, C.6
  • 38
    • 19944428546 scopus 로고    scopus 로고
    • Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): Identification of fludarabine-sensitive and -insensitive populations
    • J.R. Mackey, C.M. Galmarini, K.A. Graham, A.A. Joy, A. Delmer, and L. Dabbagh Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations Blood 105 2 2005 767 774
    • (2005) Blood , vol.105 , Issue.2 , pp. 767-774
    • MacKey, J.R.1    Galmarini, C.M.2    Graham, K.A.3    Joy, A.A.4    Delmer, A.5    Dabbagh, L.6
  • 39
    • 3242680253 scopus 로고    scopus 로고
    • Quantitative real time PCR of deoxycytidine kinase mRNA by Light Cycler PCR in relation to enzyme activity and gemcitabine sensitivity
    • J. Sigmond, J.R. Kroep, W. Loves, G. Codacci-Pisanelli, and G.J. Peters Quantitative real time PCR of deoxycytidine kinase mRNA by Light Cycler PCR in relation to enzyme activity and gemcitabine sensitivity Cancer Lett 213 2 2004 173 179
    • (2004) Cancer Lett , vol.213 , Issue.2 , pp. 173-179
    • Sigmond, J.1    Kroep, J.R.2    Loves, W.3    Codacci-Pisanelli, G.4    Peters, G.J.5
  • 40
    • 0026637308 scopus 로고
    • Resistance to 1-beta-d-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase gene
    • J.K. Owens, D.S. Shewach, B. Ullman, and B.S. Mitchell Resistance to 1-beta-d-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase gene Cancer Res 52 9 1992 2389 2393
    • (1992) Cancer Res , vol.52 , Issue.9 , pp. 2389-2393
    • Owens, J.K.1    Shewach, D.S.2    Ullman, B.3    Mitchell, B.S.4
  • 41
    • 0028336786 scopus 로고
    • Structural analysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinoside
    • M. Flasshove, D. Strumberg, L. Ayscue, B.S. Mitchell, C. Tirier, and W. Heit Structural analysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinoside Leukemia 8 5 1994 780 785
    • (1994) Leukemia , vol.8 , Issue.5 , pp. 780-785
    • Flasshove, M.1    Strumberg, D.2    Ayscue, L.3    Mitchell, B.S.4    Tirier, C.5    Heit, W.6
  • 42
    • 0035000750 scopus 로고    scopus 로고
    • Absence of mutations in the deoxycytidine kinase (dCK) gene in patients with relapsed and/or refractory acute myeloid leukemia (AML)
    • M.M. van den Heuvel-Eibrink, E.A. Wiemer, M. Kuijpers, R. Pieters, and P. Sonneveld Absence of mutations in the deoxycytidine kinase (dCK) gene in patients with relapsed and/or refractory acute myeloid leukemia (AML) Leukemia 15 5 2001 855 856
    • (2001) Leukemia , vol.15 , Issue.5 , pp. 855-856
    • Van Den Heuvel-Eibrink, M.M.1    Wiemer, E.A.2    Kuijpers, M.3    Pieters, R.4    Sonneveld, P.5
  • 43
    • 0028981978 scopus 로고
    • Multidrug resistance (Mdr1) gene expression in peripheral blasts from patients with acute leukemia only rarely increases during disease progression after combination chemotherapy
    • A. Gruber, I. Arestrom, F. Albertioni, M. Bjorkholm, C. Peterson, and S. Vitols Multidrug resistance (Mdr1) gene expression in peripheral blasts from patients with acute leukemia only rarely increases during disease progression after combination chemotherapy Leuk Lymphoma 18 5-6 1995 435 442
    • (1995) Leuk Lymphoma , vol.18 , Issue.5-6 , pp. 435-442
    • Gruber, A.1    Arestrom, I.2    Albertioni, F.3    Bjorkholm, M.4    Peterson, C.5    Vitols, S.6
  • 44
    • 0035321315 scopus 로고    scopus 로고
    • Discrepancies between the gene expression, protein expression, and enzymatic activity of thymidylate synthase and dihydropyrimidine dehydrogenase in human gastrointestinal cancers and adjacent normal mucosa
    • S. Miyamoto, A. Ochiai, N. Boku, A. Ohtsu, M. Tahara, and S. Yoshida Discrepancies between the gene expression, protein expression, and enzymatic activity of thymidylate synthase and dihydropyrimidine dehydrogenase in human gastrointestinal cancers and adjacent normal mucosa Int J Oncol 18 4 2001 705 713
    • (2001) Int J Oncol , vol.18 , Issue.4 , pp. 705-713
    • Miyamoto, S.1    Ochiai, A.2    Boku, N.3    Ohtsu, A.4    Tahara, M.5    Yoshida, S.6
  • 45
    • 2942735029 scopus 로고    scopus 로고
    • Telomerase activity level, but not hTERT mRNA and hTR level, regulates telomere length in telomerase-reconstituted primary fibroblasts
    • S.J. Swiggers, H.A. Nibbeling, A. Zeilemaker, M.A. Kuijpers, K.A. Mattern, and J.M. Zijlmans Telomerase activity level, but not hTERT mRNA and hTR level, regulates telomere length in telomerase-reconstituted primary fibroblasts Exp Cell Res 297 2 2004 434 443
    • (2004) Exp Cell Res , vol.297 , Issue.2 , pp. 434-443
    • Swiggers, S.J.1    Nibbeling, H.A.2    Zeilemaker, A.3    Kuijpers, M.A.4    Mattern, K.A.5    Zijlmans, J.M.6
  • 46
    • 0038730444 scopus 로고    scopus 로고
    • Activation of deoxycytidine kinase by gamma-irradiation and inactivation by hyperosmotic shock in human lymphocytes
    • Z. Csapo, G. Keszler, G. Safrany, T. Spasokoukotskaja, I. Talianidis, and M. Staub Activation of deoxycytidine kinase by gamma-irradiation and inactivation by hyperosmotic shock in human lymphocytes Biochem Pharmacol 65 12 2003 2031 2039
    • (2003) Biochem Pharmacol , vol.65 , Issue.12 , pp. 2031-2039
    • Csapo, Z.1    Keszler, G.2    Safrany, G.3    Spasokoukotskaja, T.4    Talianidis, I.5    Staub, M.6
  • 47
    • 0037441342 scopus 로고    scopus 로고
    • Activation of deoxycytidine kinase by UV-C-irradiation in chronic lymphocytic leukemia B-lymphocytes
    • E. Van Den Neste, C. Smal, S. Cardoen, A. Delacauw, J. Frankard, and A. Ferrant Activation of deoxycytidine kinase by UV-C-irradiation in chronic lymphocytic leukemia B-lymphocytes Biochem Pharmacol 65 4 2003 573 580
    • (2003) Biochem Pharmacol , vol.65 , Issue.4 , pp. 573-580
    • Van Den Neste, E.1    Smal, C.2    Cardoen, S.3    Delacauw, A.4    Frankard, J.5    Ferrant, A.6
  • 48
    • 2942627604 scopus 로고    scopus 로고
    • Activation of deoxycytidine kinase by protein kinase inhibitors and okadaic acid in leukemic cells
    • C. Smal, S. Cardoen, L. Bertrand, A. Delacauw, A. Ferrant, and G.V. Berghe Activation of deoxycytidine kinase by protein kinase inhibitors and okadaic acid in leukemic cells Biochem Pharmacol 68 1 2004 95 103
    • (2004) Biochem Pharmacol , vol.68 , Issue.1 , pp. 95-103
    • Smal, C.1    Cardoen, S.2    Bertrand, L.3    Delacauw, A.4    Ferrant, A.5    Berghe, G.V.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.